Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study | Zendy

Wenxing Yan | Zendy; Shuang Qiu | Zendy; Lihui Si | Zendy; Yaming Ding | Zendy; Qi Zhang | Zendy; Linlin Liu | Zendy

Open Access

Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study

Author(s) -

Wenxing Yan,

Shuang Qiu,

Lihui Si,

Yaming Ding,

Qi Zhang,

Linlin Liu

Publication year - 2020

Publication title -

translational cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.254

H-Index - 30

eISSN - 2219-6803

pISSN - 2218-676X

DOI - 10.21037/tcr.2020.02.27

Subject(s) - medicine , stage (stratigraphy) , cervical cancer , chemotherapy , oncology , retrospective cohort study , cancer , gynecology , paleontology , biology

Cervical cancer is common among women worldwide, with most cases occurring in developing countries (1). Along with the development of socioeconomics associated with urbanization, as well as the aging population, the incidence and mortality of cervical cancer keep increasing in China. It was estimated to have about 132,000 new cases and 30,000 deaths each year in China (2). Early-stage cervical cancer is mainly managed by surgical resection, with a 5-year survival rate over 90%. Radiation therapy is recommended to patients with locally advanced cervical cancer, but the prognosis is relatively poor with a 5-year survival rate Original Article

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research